Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  gallium Ga 68-DOTATATE
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients with Primary or Metastatic Gastrointestinal or Pancreatic Neuroendocrine Tumors
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: 13-C-0193, NCI-2014-02318, 335154, NCT01967537
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients with Somatostatin-Receptor Positive Tumors
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 19 and over
Trial IDs: NET0017, NCI-2014-01016, 26988, NCI-2014-00101, NCT01980732
Gallium Ga 68-DOTATATE PET/CT in Imaging Patients with Neuroendocrine or Suspected Somatostatin Receptor Positive Tumors
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: 12-001920, NCI-2016-01796, 12-001920-68Ga DOTATATE JCCCID324, NCT01873248
Start Over